AUDLEY LATE NIGHT PHARMACY LIMITED

Company Registration Number:
06954799 (England and Wales)

Unaudited abridged accounts for the year ended 30 September 2024

Period of accounts

Start date: 01 October 2023

End date: 30 September 2024

AUDLEY LATE NIGHT PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2024

Balance sheet
Notes

AUDLEY LATE NIGHT PHARMACY LIMITED

Balance sheet

As at 30 September 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 48,675 46,119
Total fixed assets: 48,675 46,119
Current assets
Stocks: 102,500 123,950
Debtors:   203,040 359,071
Cash at bank and in hand: 478,164 293,939
Total current assets: 783,704 776,960
Creditors: amounts falling due within one year:   (393,220) (453,521)
Net current assets (liabilities): 390,484 323,439
Total assets less current liabilities: 439,159 369,558
Total net assets (liabilities): 439,159 369,558
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 439,059 369,458
Shareholders funds: 439,159 369,558

The notes form part of these financial statements

AUDLEY LATE NIGHT PHARMACY LIMITED

Balance sheet statements

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 16 April 2025
and signed on behalf of the board by:

Name: Mohammed Answer Ghafoor
Status: Director

The notes form part of these financial statements

AUDLEY LATE NIGHT PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them.

Tangible fixed assets and depreciation policy

Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives: Plant & machinery 20% reducing balance Motor vehicles 25% reducing balance

Valuation and information policy

Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.

AUDLEY LATE NIGHT PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

2. Employees

2024 2023
Average number of employees during the period 21 20

AUDLEY LATE NIGHT PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

3. Tangible Assets

Total
Cost £
At 01 October 2023 218,569
Additions 14,984
At 30 September 2024 233,553
Depreciation
At 01 October 2023 172,450
Charge for year 12,428
At 30 September 2024 184,878
Net book value
At 30 September 2024 48,675
At 30 September 2023 46,119